B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
about
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity.Pathogenesis of systemic sclerosis-current concept and emerging treatments.Recent advances in the treatment of skin involvement in systemic sclerosis.Dynamics of the human antibody repertoire after B cell depletion in systemic sclerosis.Comment on B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.NRF2 Activation Inhibits Both TGF-1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment
P2860
Q33701364-BEA424D4-E7FE-445E-B343-AA7EA7F4C0D6Q39272758-660413DF-5D31-4B2C-BBE5-9A717EEA262DQ39294794-38F1943A-634E-40CF-95B7-405422F76979Q47111024-6406759E-D4B3-4381-8738-DF7BFD8D0FFBQ47754080-7C1C836B-CDA3-4177-8E1C-E9F9337AB023Q48297490-641E7551-407B-4EA4-98B7-68DB459CA0BAQ58796921-27FED277-0ED3-488F-92AF-B54335AF23E3
P2860
B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
@en
type
label
B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
@en
prefLabel
B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
@en
P2860
P356
P1476
B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
@en
P2093
Ayumi Yoshizaki
P2860
P356
10.1111/1346-8138.13184
P577
2016-01-01T00:00:00Z